Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 6/20 | 0.47 |
| ▸ | HTR2A | P28223 | 5/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4532447 | 0.98 | HRH1 (0.48) | HRH1HTR2ASIGMAR1GRM2GRM3 | |
| Tetramethylammonium Ion SCHEMBL8398859 | 0.91 | HRH1 (0.43) | HRH1HTR2ASIGMAR1GRM2GRM3 | |
| Tetrylammonium SCHEMBL8395108 | 0.87 | SIGMAR1 (0.41) | HRH1HTR2ASIGMAR1GRM2GRM3 | |
| Tetrabuthylammonium SCHEMBL8398750 | 0.83 | SIGMAR1 (0.39) | HRH1HTR2ASIGMAR1KCNH2 | |
| SCHEMBL8400397 | 0.82 | HRH1 (0.39) | HRH1HTR2ASIGMAR1GRM2GRM3 | |
| SCHEMBL8398517 | 0.82 | HTR2A (0.40) | HRH1HTR2ASIGMAR1KCNH2 | |
| SCHEMBL5858776 | 0.82 | CYP19A1 (0.41) | HRH1HTR2ACYP19A1 | |
| SCHEMBL8650611 | 0.78 | LMNA (0.35) | HRH1HTR2AKCNH2 | |
| Tetramethylammonium Ion SCHEMBL8396033 | 0.78 | CYP19A1 (0.38) | HRH1HTR2ACYP19A1 | |
| SCHEMBL7784138 | 0.76 | HRH1 (0.58) | HRH1HTR2ASIGMAR1CYP19A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120941-A1 | ADHESIVE AGENT FOR ADHESION BETWEEN ALGINATE IMPRESSION MATERIAL FOR DENTAL APPLICATIONS AND IMPRESSION TRAY, AND KIT COMPRISING THE ADHESIVE AGENT | TOKUYAMA DENTAL CORPORATION (JP) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120941-A1 | ADHESIVE AGENT FOR ADHESION BETWEEN ALGINATE IMPRESSION MATERIAL FOR DENTAL APPLICATIONS AND IMPRESSION TRAY, AND KIT COMPRISING THE ADHESIVE AGENT | ICAM1, ITGB8, TRA2B | HRH1 1367/4885HTR2A 543/4885SIGMAR1 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.